Tepedict 150mg Tablet ER
Marketer
Brainwave Healthcare Pvt Ltd
Salt Composition
Tapentadol (150mg)
Overview Tepedict 150mg Tablet ER
Axalgesic ER 150mg tablets provide relief from moderate to severe acute pain in adults. Indicated for various conditions including headaches, fever, menstrual cramps, dental pain, and common colds, it's effective when other analgesics prove insufficient. Dosage and frequency should strictly adhere to your physician's instructions. This medication carries a significant risk of dependence. Potential side effects include nausea, somnolence, emesis, and vertigo. Pre-existing cardiac, hepatic, or renal conditions must be disclosed to your doctor. Seek medical advice if pregnant, considering pregnancy, or breastfeeding.
Primary Ingredients of Tepedict 150mg Tablet ER
No text was provided to rewrite.
Uses of Tepedict 150mg Tablet ER
Significant to intense pain
Major Benefits of Tepedict 150mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tepedict 150mg Extended-Release Tablets can be consumed with or without food, however, consistent daily timing is recommended.
Common Side effects of Tepedict 150mg Tablet ER:
- Nausea
- Vomiting
- Dizziness
- Sleepiness
How to use Tepedict 150mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Tepedict 150mg Extended-Release tablet whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistent timing is recommended.
How Tepedict 150mg Tablet ER works:
Extended-release Tepedict 150mg tablets reduce pain sensation by inhibiting the passage of pain impulses to the central nervous system.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tepedict 150mg Extended-Release Tablets and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tepedict 150mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. Prescribing will involve a physician's assessment of benefits versus potential risks. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Tepedict 150mg tablets may pose a risk to breastfeeding infants. Available evidence from human studies indicates potential transfer of the medication into breast milk, possibly resulting in infant harm.
DrivingUNSAFE
Extended-release Tepedict 150mg tablets can induce adverse reactions that impair driving ability. Refrain from operating a vehicle if drowsiness, dizziness, blurred vision, or slowed reflexes occur during treatment with Tepedict 150mg ER tablets.
KidneyCAUTION
Extended-release Tepedict 150mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Tepedict 150mg ER tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Tepedict 150mg Extended-Release tablets to patients exhibiting severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Tepedict 150mg Extended-Release tablets are contraindicated in patients with severe renal dysfunction.
What if you forget to take Tepedict 150mg Tablet ER :
Omit any missed dose of Tepedict 150mg Extended-Release Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Tepedict 150mg Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Phenylpropanoid |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
3,018 People bought this recently